AlphaStocks
5.2
Consider Buy

Waystar Holding Corp. (WAY)

As of Sep 20, 2026, Waystar Holding Corp. (WAY) scores 5.2/10 on AlphaStocks' five-model composite, #101 of 168 Health Care stocks. At $26, WAY trades 3% below its model fair value of $26.

Health Care / Health Care Technology

S&P SmallCap 600

$25.67

Below average on several measures. Research carefully.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#101out of 168 in Health Care

Is Waystar Holding Corp. a Good Investment in 2026?

Waystar Holding Corp. (WAY) scores 5.2 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Waystar Holding Corp. as Strong (7/9). However, the Graham model rates it Caution — 31% above fair value. Waystar Holding Corp. currently trades 3% below its estimated fair value of $26. Waystar Holding Corp. ranks #101 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E42.3ROE3.1Market Cap5B

Estimated Fair Value

$26.483% below

Trading near estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

31% above fair value

Lynch

Limited Data

Growth rate vs price (PEG)

Greenblatt

Neutral

Earnings yield 4.5% · ROC 60%

Frequently Asked Questions

Is Waystar Holding Corp. (WAY) a good investment?
As of Sep 20, 2026, Waystar Holding Corp. (WAY) scores 5.2/10 on AlphaStocks' five-model composite, #101 of 168 Health Care stocks. At $26, WAY trades 3% below its model fair value of $26. That score is below average, suggesting caution.
What is Waystar Holding Corp.'s Piotroski F-Score?
Waystar Holding Corp.'s Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is WAY overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $26, WAY appears undervalued. The stock currently trades 3% below its estimated fair value. Trading near estimated fair value.
How does WAY compare to other Health Care stocks?
Waystar Holding Corp. ranks #101 out of 168 stocks in the Health Care sector, placing it in the top 60% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about WAY?
AlphaStocks evaluates WAY using five proven investment models. Piotroski: Strong; Buffett: Neutral; Graham: Caution; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 5.2/10.

Similar Stocks

SOLVVEEVCERT

Compare WAY with

SOLV vs WAYVEEV vs WAYCERT vs WAYVAL vs WAY

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer